NO165961C - Fremgangsmaate til fremstilling av interferonproteiner. - Google Patents

Fremgangsmaate til fremstilling av interferonproteiner.

Info

Publication number
NO165961C
NO165961C NO801133A NO801133A NO165961C NO 165961 C NO165961 C NO 165961C NO 801133 A NO801133 A NO 801133A NO 801133 A NO801133 A NO 801133A NO 165961 C NO165961 C NO 165961C
Authority
NO
Norway
Prior art keywords
procedure
manufacture
interferon proteins
interferon
proteins
Prior art date
Application number
NO801133A
Other languages
English (en)
Norwegian (no)
Other versions
NO165961B (no
NO801133L (no
Inventor
Kurt Frimann Berg
Original Assignee
Technobiotic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27220922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO165961(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Technobiotic Ltd filed Critical Technobiotic Ltd
Publication of NO801133L publication Critical patent/NO801133L/no
Priority to NO884472A priority Critical patent/NO884472D0/no
Publication of NO165961B publication Critical patent/NO165961B/no
Publication of NO165961C publication Critical patent/NO165961C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO801133A 1979-04-20 1980-04-18 Fremgangsmaate til fremstilling av interferonproteiner. NO165961C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO884472A NO884472D0 (no) 1979-04-20 1988-10-07 Antistoffer og fremgangsmaater for fremstilling derav.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK164579 1979-04-20
DK79180 1980-02-22
DK148480 1980-04-02

Publications (3)

Publication Number Publication Date
NO801133L NO801133L (no) 1980-12-18
NO165961B NO165961B (no) 1991-01-28
NO165961C true NO165961C (no) 1991-05-15

Family

ID=27220922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO801133A NO165961C (no) 1979-04-20 1980-04-18 Fremgangsmaate til fremstilling av interferonproteiner.

Country Status (15)

Country Link
EP (2) EP0091543B1 (es)
JP (2) JPH0742317B2 (es)
AU (1) AU539494B2 (es)
CA (1) CA1168151A (es)
DE (2) DE3072134D1 (es)
ES (1) ES8103976A1 (es)
FI (1) FI77877C (es)
HK (1) HK22792A (es)
IE (1) IE55791B1 (es)
IL (1) IL59880A (es)
NO (1) NO165961C (es)
NZ (1) NZ193487A (es)
PT (1) PT71111A (es)
SG (1) SG92591G (es)
WO (1) WO1980002229A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
US4530901A (en) * 1980-01-08 1985-07-23 Biogen N.V. Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
DE3005843A1 (de) * 1980-02-16 1981-09-10 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
ATE56471T1 (de) 1980-04-03 1990-09-15 Biogen Inc Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
GB2083836B (en) * 1980-04-11 1984-03-28 Burke Derek Clissold Monoclonal antibody
CH657141A5 (de) * 1980-07-01 1986-08-15 Hoffmann La Roche Dns-sequenzen, rekombinante expressionsvektoren zur mikrobiellen herstellung von human-leukozyten-interferonen und transformierte mikroorganismen.
FR2492842A1 (fr) * 1980-10-24 1982-04-30 Centre Nat Rech Scient Hybride cellulaire produisant un anticorps specifique de l'interferon leucocytaire humain et procede de formation d'hybrides cellulaires producteurs d'anticorps specifiques de l'interferon humain
EP0064063B1 (en) * 1980-11-07 1985-09-11 Celltech Limited Assay for interferon
JPS58500037A (ja) * 1980-11-07 1983-01-06 セルテク　リミテツド インタ−フェロンの検定法
AU561649B2 (en) * 1981-02-27 1987-05-14 F. Hoffmann-La Roche Ag Antibodies to proteins
DE3280127D1 (de) * 1981-03-27 1990-04-12 Ici Plc Genetisch modifizierte mikroorganismen.
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
EP0085693A1 (en) * 1981-08-14 1983-08-17 A/S Alfred Benzon Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies
IE54592B1 (en) * 1982-03-08 1989-12-06 Genentech Inc Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
US6432677B1 (en) 1982-03-08 2002-08-13 Genentech, Inc. Non-human animal interferons
US5827694A (en) * 1982-03-08 1998-10-27 Genentech, Inc. DNA encoding non-human animal interferons, vectors and hosts therefor, and recombinant production of IFN polypeptides
JPS58201794A (ja) * 1982-05-17 1983-11-24 Toray Ind Inc ヒトインターフェロンβの濃縮精製法
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4534906A (en) * 1982-11-01 1985-08-13 Genentech, Inc. Removal of impurities from human leukocyte interferon preparations
US5831023A (en) * 1982-11-01 1998-11-03 Genentech, Inc. Recombinant animal interferon polypeptides
DE3306060A1 (de) * 1983-02-22 1984-08-23 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
EP0490233A1 (de) * 1986-03-10 1992-06-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Monoclonale Antikörper gegen BgIII-Hybridinterferone, deren Verwendung und Verfahren zu ihrer Herstellung
DE3607835A1 (de) * 1986-03-10 1987-09-24 Boehringer Ingelheim Int Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
DE3633323A1 (de) * 1986-10-01 1988-04-07 Boehringer Ingelheim Int Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega
US5391713A (en) * 1989-06-20 1995-02-21 Bionative Ab Interferon purification process
SE468251B (sv) 1989-06-20 1992-11-30 Bionative Ab Reningsprocess foer interferon
PL176408B1 (pl) * 1992-02-10 1999-05-31 Interferon Sciences Inc Kompozycja naturalnego alfa interferonu z ludzkich leukocytów krwi obwodowej i sposób wytwarzania kompozycji naturalnego alfa interferonu z ludzkich leukocytów krwi obwodowej
US5676942A (en) * 1992-02-10 1997-10-14 Interferon Sciences, Inc. Composition containing human alpha interferon species proteins and method for use thereof
JP4706093B2 (ja) * 2000-09-25 2011-06-22 富士レビオ株式会社 パルボウイルスの除去方法及び精製方法
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
NL7703281A (nl) * 1977-03-25 1978-09-27 Stichting Rega V Z W Werkwijze voor het bereiden van interferon.
FR2389380B1 (es) * 1977-05-02 1980-02-29 Anvar
IN150740B (es) * 1978-11-24 1982-12-04 Hoffmann La Roche
NO164037C (no) * 1980-01-08 1990-08-22 Biogen Inc Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type.
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain

Also Published As

Publication number Publication date
AU539494B2 (en) 1984-10-04
EP0091543A1 (en) 1983-10-19
PT71111A (en) 1980-05-01
EP0018218A1 (en) 1980-10-29
IE800796L (en) 1980-10-20
ES490697A0 (es) 1981-04-16
NO165961B (no) 1991-01-28
NZ193487A (en) 1983-07-15
WO1980002229A1 (en) 1980-10-30
JPH02198A (ja) 1990-01-05
IE55791B1 (en) 1991-01-16
JPS56500536A (es) 1981-04-23
ES8103976A1 (es) 1981-04-16
EP0018218B1 (en) 1988-11-23
IL59880A0 (en) 1980-06-30
EP0091543B1 (en) 1989-06-14
AU5759980A (en) 1980-10-23
IL59880A (en) 1984-03-30
JPH0742317B2 (ja) 1995-05-10
DE3072134D1 (en) 1988-12-29
FI77877B (fi) 1989-01-31
HK22792A (en) 1992-04-03
DE91543T1 (de) 1984-12-20
FI77877C (fi) 1989-05-10
NO801133L (no) 1980-12-18
CA1168151A (en) 1984-05-29
SG92591G (en) 1993-02-19
FI801215A (fi) 1980-10-21
JPH0794480B2 (ja) 1995-10-11

Similar Documents

Publication Publication Date Title
NO165961C (no) Fremgangsmaate til fremstilling av interferonproteiner.
NO156051C (no) Fremgangsmaate for fremstilling av type ii-interferon.
NO152976C (no) Fremgangsmaate for fremstilling av interferon.
NO145367C (no) Fremgangsmaate for fremstilling av funksjonelt protein
NO155434C (no) Fremgangsmaate for fremstilling av forfalskningssikre dokumenter.
NO822722L (no) Fremgangsmaate til fremstilling av benzazepin-2-oner.
NO163668C (no) Fremgangsmaate for fremstilling av immunogent kompleks.
IT8024457A0 (it) Procedimento di fabbricazione di 5-idrossimetilfurfurolo.
NO159667C (no) Fremgangsmaate for fremstilling av kikhostetoksid.
NO803591L (no) Fremgangsmaate for fremstilling av fiskemel.
NO157861C (no) Analogifremgangsmaate til fremstilling av aminopyridaziner.
NO155051C (no) Fremgangsmaate for fremstilling av alfa-klorerte klorformiaer.
DK150986C (da) Fremgangsmaade til fremstilling af azopigmentpraeparater
NO822634L (no) Fremgangsmaate for fremstilling av cefemderivater.
NO150888C (no) Fremgangsmaate for fremstilling av et encelle-protein
NO812519L (no) Fremgangsmaate for fremstilling av kolesterase.
NO157735C (no) Fremgangsmaate for fremstilling av alfa-arylalkansyrer.
NO153853C (no) Fremgangsmaate for fremstilling av 17beta-hydroksy-17alfa-pregn-5-en-21-karboksylsyre-gamma-laktoner.
NO845071L (no) Fremgangsmaate til fremstilling av ferromangan.
NO162018C (no) Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler.
NO801142L (no) Fremgangsmaate til fremstilling av klordioksyd.
NO152840C (no) Fremgangsmaate for fremstilling av dibenzyletere.
NO157652C (no) Fremgangsmaate for fremstilling av 3-pikolin.
NO155732C (no) Fremgangsmaate for fremstilling av kijanimicin.
NO811038L (no) Fremgangsmaate til fremstilling av insulin.